Delivery Order SPE2DR25D1104-SPE2DR26FK610
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,755.54 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, and represents a non-set-aside competitive award. The delivery order is issued under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,744.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This firm fixed price delivery order, issued on December 5, 2025, with completion targeted for December 8, 2025, represents a non-competitive award under a larger contract vehicle. The pharmaceutical products will be delivered to support federal healthcare operations, with AmerisourceBergen's place...
- The Defense Logistics Agency (DLA) awarded a $1,744.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL quantity) on December 8, 2025, with completion targeted for December 9, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,970.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and carries firm fixed pricing with no set-aside designation. The award represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle with DLA, reflecting the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,201.66 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen (0.5 ml), a diabetes medication. This firm fixed-price delivery order, issued on December 2, 2025, with completion targeted for December 3, 2025, was not set-aside and was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5ml units), a diabetes medication. This non-set-aside, firm fixed-price delivery order was awarded on December 10, 2025, with an ultimate completion date of December 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,956.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $11,440.24. The contract, which was competitively awarded without set-aside designation, is firm fixed price and has an ultimate completion date of November 25, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,108.74 to supply Trulicity 1.5 mg/0.5 mL pens on a firm fixed price basis, with an ultimate completion date of September 3, 2025. This is a non-set-aside competitive award where the pharmaceutical distributor will fulfill the delivery order from its facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major healthcare solutions provider and pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,553.83 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on December 10, 2025, with completion scheduled for December 11, 2025. This competitive award uses firm fixed pricing with no set-aside designation and is performed at the contractor's headquarters in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK610Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,189.40 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL vials), a diabetes medication. This firm fixed-price delivery order, awarded on December 9, 2025, with completion targeted for December 10, 2025, was issued without a set-aside designation and represents a competitively awarded transaction. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor within the federal medical supply chain, particularly for military and veteran healthcare systems. The company's substantial IDC with DLA enables the delivery of comprehensive pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare customers globally. This specific delivery order for Trulicity exemplifies the company's role in supplying brand-name medications essential to military medical readiness and personnel healthcare support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/8/25 |